About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Ighg1
immunoglobulin heavy constant gamma 1 (G1m marker)
MGI:96446
62 phenotypes from multigenic genotypes
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Bcl6tm1.1Mtto/Bcl6tm1.1Mtto
Ighg1tm1(cre)Cgn/Ighg1+
involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JJcl 		decreased germinal center B cell number J:190943
normal immune system phenotype J:190943
Col1a1tm1(CAG-Ezh2*)Meln/Col1a1+
Ighg1tm1(cre)Cgn/Ighg1+
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 		normal immune system phenotype J:199122
increased germinal center B cell number J:199122
increased spleen germinal center number J:199122
increased spleen germinal center size J:199122
normal neoplasm J:199122
Ebf1tm1.1Rug/Ebf1tm1.1Rug
Ighg1tm1(cre)Cgn/Ighg1+
involves: 129P2/OlaHsd * C57BL/6 * SJL 		decreased germinal center B cell number J:182210
Ezh2tm1Tara/Ezh2tm1Tara
Ighg1tm1(cre)Cgn/Ighg1+
involves: 129P2/OlaHsd 		decreased B cell proliferation J:199122
decreased germinal center B cell number J:199122
decreased IgG1 level J:199122
decreased IgG2b level J:199122
decreased IgG3 level J:199122
decreased spleen germinal center number J:199122
decreased spleen germinal center size J:199122
normal immune system phenotype J:199122
Fcer2atm1Max/Fcer2atm1Max
Ighg1tm1.1Pyu/Ighg1+
involves: 129 * BALB/cJ * C57BL/6 * C57BL/6J 		decreased body temperature J:198154
decreased IgG1 level J:198154
decreased IgG2c level J:198154
decreased IgG level J:198154
increased IgE level J:198154
increased IgG2a level J:198154
increased susceptibility to type I hypersensitivity reaction J:198154
increased susceptibility to xenobiotic induced morbidity/mortality J:198154
Fcer2atm1Max/Fcer2atm1Max
Ighg1tm1.1Pyu/Ighg1tm1.1Pyu
involves: 129 * BALB/cJ * C57BL/6 * C57BL/6J 		abnormal immunoglobulin level J:198154
decreased body temperature J:198154
decreased IgG2c level J:198154
decreased IgG level J:198154
increased IgE level J:198154
increased IgG2a level J:198154
increased susceptibility to type I hypersensitivity reaction J:198154
increased susceptibility to xenobiotic induced morbidity/mortality J:198154
Gm614tm1.1Cya/Gm614tm1.1Cya
Ighg1tm1(cre)Cgn/Ighg1+
involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N 		decreased susceptibility to systemic lupus erythematosus J:307345
normal immune system phenotype J:307345
increased B cell apoptosis J:307345
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
Prdm1tm2Masu/Prdm1tm2Masu
involves: 129P2/OlaHsd * 129X1/SvJ 		abnormal germinal center B cell physiology J:167612
abnormal plasma cell differentiation J:167612
decreased IgG1 level J:167612
decreased survivor rate J:167612
enlarged liver J:167612
enlarged lymph nodes J:167612
enlarged spleen J:167612
increased B cell derived lymphoma incidence J:167612
increased germinal center B cell number J:167612
premature death J:167612
Gt(ROSA)26Sortm1(gp80,EGFP)Eces/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6) 		abnormal class switch recombination J:172031
absent spleen germinal center J:172031
decreased B cell number J:172031
decreased follicular B cell number J:172031
decreased germinal center B cell number J:172031
decreased IgA level J:172031
decreased IgG1 level J:172031
decreased IgG2a level J:172031
decreased IgG2b level J:172031
decreased IgG3 level J:172031
decreased plasma cell number J:172031
decreased tumor-free survival time J:172031
enlarged spleen J:172031
increased B cell number J:172031
increased histiocytic sarcoma incidence J:172031
increased IgE level J:172031
increased macrophage cell number J:172031
increased marginal zone B cell number J:172031
increased sarcoma incidence J:172031
increased spleen weight J:172031
increased tumor incidence J:172031
Gt(ROSA)26Sortm4(Ikbkb)Rsky/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
involves: 129P2/OlaHsd * C57BL/6 		abnormal spleen morphology J:167612
decreased germinal center B cell number J:167612
enlarged spleen J:167612
increased B cell number J:167612
increased IgG1 level J:167612
increased IgM level J:167612
increased plasma cell number J:167612
Gt(ROSA)26Sortm4(Ikbkb)Rsky/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
Prdm1tm2Masu/Prdm1tm2Masu
involves: 129P2/OlaHsd * C57BL/6 		abnormal germinal center B cell physiology J:167612
abnormal plasma cell differentiation J:167612
decreased IgG1 level J:167612
decreased survivor rate J:167612
increased B cell derived lymphoma incidence J:167612
increased germinal center B cell number J:167612
premature death J:167612
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/Gt(ROSA)26Sortm13(CAG-MYC,-CD2*)Rsky
Ighg1tm1(cre)Cgn/Ighg1+
involves: 129P2/OlaHsd * C57BL/6 		abnormal class switch recombination J:191824
increased B cell derived lymphoma incidence J:191824
increased germinal center B cell number J:191824
premature death J:191824
Gt(ROSA)26Sortm12(CD2*)Rsky/Gt(ROSA)26Sor+
Myctm2Fwa/Myctm2Fwa
Ighg1tm1(cre)Cgn/Ighg1+
involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 		decreased spleen germinal center size J:188564
Gt(ROSA)26Sortm13(CAG-MYC,-CD2*)Rsky/Gt(ROSA)26Sor+
Myctm2Fwa/Myctm2Fwa
Ighg1tm1(cre)Cgn/Ighg1+
involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 		normal immune system phenotype J:188564
Ighg1tm1(cre)Cgn/Ighg1+
Irf4tm1Rdf/Irf4tm1.1Rdf
involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6 		abnormal class switch recombination J:112643
abnormal memory B cell morphology J:112643
absent plasma cells J:112643
decreased IgG1 level J:112643
normal immune system phenotype J:112643
Ighg1tm1(cre)Cgn/Ighg1+
Myd88em1.1Rsky/Myd88+
involves: 129P2/OlaHsd * C57BL/6NTac 		abnormal somatic hypermutation frequency J:308792
abnormal splenic cell ratio J:308792
normal hematopoietic system phenotype J:308792
increased germinal center B cell number J:308792
increased IgM level J:308792
increased plasma cell number J:308792
Ighg1tm1(cre)Cgn/Ighg1+
Tbl1xr1tm1c(EUCOMM)Hmgu/Tbl1xr1tm1c(EUCOMM)Hmgu
involves: 129P2/OlaHsd * C57BL/6J 		abnormal B cell differentiation J:292118
abnormal spleen morphology J:292118
Ighg1tm1(cre)Cgn/Ighg1+
Tbl1xr1tm1.1Meln/Tbl1xr1+
involves: 129P2/OlaHsd * C57BL/6J 		abnormal B cell differentiation J:292118
abnormal spleen morphology J:292118
Ighg1tm1(cre)Cgn/0
Mef2btm1.1Rdf/Mef2b+
involves: 129P2/OlaHsd * C57BL/6 		decreased germinal center B cell number J:265465
Ighg1tm1(cre)Cgn/0
Mef2btm1.1Rdf/Mef2btm1.1Rdf
involves: 129P2/OlaHsd * C57BL/6 		abnormal mature B cell morphology J:265465
decreased germinal center B cell number J:265465
Ighg1tm1(cre)Cgn/0
Mef2btm1.1Rdf/Mef2btm1.1Rdf
Mef2ctm2Eno/Mef2ctm2Eno
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 		decreased germinal center B cell number J:265465
Ighg1tm1(cre)Cgn/0
Mef2btm2Rdf/Mef2b+
involves: 129P2/OlaHsd * C57BL/6 		abnormal mature B cell morphology J:265465
increased germinal center B cell number J:265465
Ighg1tm1(cre)Cgn/0
Mef2btm2Rdf/Mef2btm1.1Rdf
involves: 129P2/OlaHsd * C57BL/6 		abnormal mature B cell morphology J:265465
increased germinal center B cell number J:265465
Ighg1tm1(cre)Cgn/0
Mef2ctm2Eno/Mef2ctm2Eno
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 		decreased germinal center B cell number J:265465
Ighg1tm1(cre)Cgn/0
Mef2dtm3Eno/Mef2dtm3Eno
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 		normal hematopoietic system phenotype J:265465
Ighmtm1Cgn/Ighm+
Tg(Igh-6/Igh-V125)2Jwt/0
Tg(Igk-C/Igk-V125)1Jwt/0
NOD.Cg-Ighmtm1Cgn Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt 		increased circulating glucose level J:91865
increased susceptibility to autoimmune diabetes J:91865
insulitis J:91865
Ighmtm1Cgn/Ighmtm1Cgn
Tg(Igh-6/Igh-V125)2Jwt/0
Tg(Igk-C/Igk-V125)1Jwt/0
NOD.Cg-Ighmtm1Cgn Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt 		insulitis J:91865
Igkctm2(IGKC)Cgn/Igkctm2(IGKC)Cgn
Ighg1tm1(IGHG1)Rsky/Ighg1tm1(IGHG1)Rsky
involves: 129P2/OlaHsd 		normal immune system phenotype J:127217
Kmt2dtm1.1Kaig/Kmt2d+
Ighg1tm1(cre)Cgn/Ighg1+
Tg(Vav-BCL2)69Jad/0
involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J 		increased B cell derived lymphoma incidence J:228913
increased follicular lymphoma incidence J:228913
premature death J:228913
Kmt2dtm1.1Kaig/Kmt2dtm1.1Kaig
Ighg1tm1(cre)Cgn/Ighg1+
involves: 129P2/OlaHsd * C57BL/6 		normal immune system phenotype J:228913
Kmt2dtm1.1Kaig/Kmt2dtm1.1Kaig
Ighg1tm1(cre)Cgn/Ighg1+
Tg(Vav-BCL2)69Jad/0
involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J 		increased B cell derived lymphoma incidence J:228913
increased follicular lymphoma incidence J:228913
premature death J:228913
Mir146tm1.1Lfl/Mir146tm1.1Lfl
Ighg1tm1(cre)Cgn/Ighg1+
involves: 129P2/OlaHsd * C57BL/6 		increased germinal center B cell number J:266124
increased T follicular helper cell number J:266124
Tg(Igh-6/Igh-V125)2Jwt/0
Tg(Igk-C/Igk-V125)1Jwt/0
NOD.B6-Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt 		abnormal B cell number J:91865
increased circulating glucose level J:91865
increased susceptibility to autoimmune diabetes J:91865
insulitis J:91865
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory